Susceptibility of different mouse wild type strains to develop diet-induced NAFLD/AFLD-associated liver disease VHI Fengler, T Macheiner, SM Kessler, B Czepukojc, K Gemperlein, ... PloS one 11 (5), e0155163, 2016 | 80 | 2016 |
Adiponectin serum concentrations in men with coronary artery disease: the LUdwigshafen RIsk and Cardiovascular Health (LURIC) study S Pilz, W Maerz, G Weihrauch, K Sargsyan, G Almer, M Nauck, BO Boehm, ... Clinica chimica acta 364 (1-2), 251-255, 2006 | 69 | 2006 |
Respiratory chain complex I is a mitochondrial tumor suppressor of oncocytic tumors Franz A. Zimmermann1, Johannes A. Mayr1, Rene Feichtinger1, Daniel Neureiter2, Roman … M Ratschek, H Rusmir, K Sargsyan, W Sperl, B Kofler Frontiers in Bioscience 3, 315-325, 2011 | 54 | 2011 |
Magnetomitotransfer: An efficient way for direct mitochondria transfer into cultured human cells T Macheiner, VHI Fengler, M Agreiter, T Eisenberg, F Madeo, D Kolb, ... Scientific Reports 6 (1), 35571, 2016 | 49 | 2016 |
Managing Obstetric Emergencies and Trauma (MOET) structured skills training in Armenia, utilising models and reality based scenarios RB Johanson, V Menon, E Burns, E Kargramanya, V Osipov, M Israelyan, ... BMC Medical Education 2, 1-7, 2002 | 49 | 2002 |
Sustainability in biobanking: model of Biobank Graz K Sargsyan, T Macheiner, P Story, M Strahlhofer-Augsten, K Plattner, ... Biopreservation and biobanking 13 (6), 410-420, 2015 | 30 | 2015 |
Evaluation of risk profiles by subcutaneous adipose tissue topography in obese juveniles R Moeller, R Horejsi, S Pilz, N Lang, K Sargsyan, R Dimitrova, E Tafeit, ... Obesity 15 (5), 1319-1324, 2007 | 30 | 2007 |
Challenges and driving forces for business plans in biobanking T Macheiner, B Huppertz, M Bayer, K Sargsyan Biopreservation and Biobanking 15 (2), 121-125, 2017 | 23 | 2017 |
Biobank Graz: the hub for innovative biomedical research B Huppertz, M Bayer, T Macheiner, K Sargsyan Open journal of bioresources 3, e3-e3, 2016 | 19 | 2016 |
Overview of cancer control in Armenia and policy implications K Bedirian, T Aghabekyan, A Mesrobian, S Shekherdimian, D Zohrabyan, ... Frontiers in Oncology 11, 782581, 2022 | 18 | 2022 |
The evaluation of biomarkers of physical activity on stress resistance and wellness A Muradyan, T Macheiner, M Mardiyan, E Sekoyan, K Sargsyan Applied Psychophysiology and Biofeedback 47 (2), 121-129, 2022 | 13 | 2022 |
Innovative ways for information transfer in biobanking T Macheiner, B Huppertz, K Sargsyan Campus-Wide Information Systems 30 (5), 379-385, 2013 | 13 | 2013 |
Quality management at the national biobanking level–establishing a culture of mutual trust and support: the BBMRI. at example H Haslacher, M Bayer, H Fiegl, M Gerner, P Hofer, M Korb, S Neururer, ... Clinical Chemistry and Laboratory Medicine (CCLM) 57 (12), e301-e305, 2019 | 10 | 2019 |
Biobanking: Sustainable use of biological resources on the example of the Biobank Graz T Macheiner, B Huppertz, K Sargsyan Der Pathologe 34, 366-369, 2013 | 9* | 2013 |
Hypoadiponectinemia as a risk factor for atherosclerosis? S Pilz, K Sargsyan, H Mangge Stroke 37 (7), 1642-1642, 2006 | 9 | 2006 |
Crucial role of high quality biosamples in biomarker development C Stumptner, K Sargsyan, P Kungl, K Zatloukal Handbook of biomarkers and precision medicine, 128-134, 2019 | 7 | 2019 |
Applied Molecular-Based Quality Control of Biobanked Samples for Multi-Omics Approach A Michalska-Falkowska, J Niklinski, H Juhl, A Sulewska, J Kisluk, ... Cancers 15 (14), 3742, 2023 | 6 | 2023 |
Risk management in biobanks K Sargsyan, B Jaksa, G Hartl, T Macheiner Risk Management and Assessment, 71, 2020 | 6 | 2020 |
Manifestation of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Different Dietary Mouse Models VHI Fengler, T Macheiner, K Sargsyan European Medical. Journal Hepatology 4, 94-102, 2016 | 6 | 2016 |
The Economic Cycles on Economic System Development, and the Causes of Their Emergence, Current Issues on Social and Economic Development in the Republic of Armenia. Materials … K Sargsyan Yerevan, 312-317, 2012 | 5 | 2012 |